Valius Sciences
Valius Sciences offers exhaustive tumour profiling for rare and advanced cancers, what it calls maximalist diagnostics for the toughest cases, and has raised 13 million dollars to build it.
Overview
Valius Sciences runs exhaustive molecular and functional profiling of a patient's tumour to find therapeutic targets and treatment options in rare and advanced cancers, working with the patient's physicians; its team includes the physicians Bicky Thapa and Katherine Fuh. The company announced a 13 million dollar raise to transform cancer diagnostics, and Sid Sijbrandij, the GitLab co-founder whose osteosarcoma led to the Even One Ventures portfolio, describes using it. It also appears on the Sijbrandij Foundation's Future of Cancer Care Today list.
Funding
All startupsSimilar pages
not linked directly; found by shared links- CompanyKernis Health
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyPalitra Bio
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.